Patents by Inventor Nicola Pescosolido

Nicola Pescosolido has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140079809
    Abstract: The use of L-carnitine, in combination with antioxidants such as vitamin E and inorganic elements such as manganese, zinc, sodium and potassium, for the preparation of a physiological supplement or medicament for ophthalmic use, for the prevention or treatment of accomodative asthenopia is disclosed.
    Type: Application
    Filed: November 18, 2013
    Publication date: March 20, 2014
    Applicant: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Nicola PESCOSOLIDO, Aleardo KOVERECH
  • Patent number: 8389014
    Abstract: The present invention relates to a solid powder composed of a mixture of a natural or a synthetic polymer which forms a gel, a buffer, such as an hydroxyacid or a dicarboxyacid, a saccharide, one or more drugs useful for the treatment of diseases of the eyes and optionally one or more excipients and/or regulators of the osmotic pressure ophthalmologically acceptable.
    Type: Grant
    Filed: November 28, 2007
    Date of Patent: March 5, 2013
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Antonio Longo, Mose Santaniello, Nicola Pescosolido, Aleardo Koverech
  • Publication number: 20130045940
    Abstract: It is described a composition in the form of eye drops or ointment, comprising as active ingredients L-carnitine or a physiologically acceptable salt thereof; and 3-Hydroxykynurenine O-?-DL-glucoside, useful for preventing or treating pathologies of the eyes due to ultraviolet radiation.
    Type: Application
    Filed: February 10, 2011
    Publication date: February 21, 2013
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Nicola Pescosolido, Aleardo Koverech
  • Patent number: 8377988
    Abstract: Use of L-carnitine and/or of one or more alkanoyl L-carnitines or one of their pharmaceutically acceptable salts for the preparation of an ophthalmic physiological supplement or medicament in the form of eye-drops, for the treatment of corneal diseases.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: February 19, 2013
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite SpA
    Inventors: Aleardo Koverech, Nicola Pescosolido
  • Patent number: 8158679
    Abstract: Use of L-carnitine or a pharmaceutically acceptable salt thereof, for the preparation of an ophthalmic physiological supplement or medicament in the form of eye-drops, for the treatment of corneal oedema.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: April 17, 2012
    Assignee: SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Aleardo Koverech, Nicola Pescosolido
  • Publication number: 20110268817
    Abstract: It is described the use of L-carnitine, in combination with antioxidants such as vitamin E and inorganic elements such as manganese, zinc, sodium and potassium, for the preparation of a physiological supplement or medicament for opthalmic use, for the prevention or treatment of accomodative asthenopia.
    Type: Application
    Filed: June 25, 2009
    Publication date: November 3, 2011
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Nicola Pescosolido, Aleardo Koverech
  • Publication number: 20100093858
    Abstract: Use of L-carnitine and/or of one or more alkanoyl L-carnitines or one of their pharmaceutically acceptable salts for the preparation of an opthalmic physiological supplement or medicament in the form of eye-drops, for the treatment of corneal diseases.
    Type: Application
    Filed: December 18, 2009
    Publication date: April 15, 2010
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Aleardo Koverech, Nicola Pescosolido
  • Publication number: 20100068300
    Abstract: Use of L-carnitine or a pharmaceutically acceptable salt thereof, for the preparation of an opthalmic physiological supplement or medicament in the form of eye-drops, for the treatment of corneal oedema.
    Type: Application
    Filed: November 21, 2007
    Publication date: March 18, 2010
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Aleardo Koverech, Nicola Pescosolido
  • Publication number: 20100069482
    Abstract: It is described a gel composed of a mixture of a polymer which forms a gel, a buffer; a saccharide and one or more active ingredients useful for treating diseases of the eyes.
    Type: Application
    Filed: November 28, 2007
    Publication date: March 18, 2010
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Antonio Longo, Mosè Santaniello, Nicola Pescosolido, Aleardo Koverech
  • Patent number: 7655698
    Abstract: Use of L-carnitine and/or of one or more alkanoyl L-carnitines or one of their pharmaceutically acceptable salts for the preparation of an ophthalmic physiological supplement or medicament in the form of eye-drops, for the treatment of corneal diseases.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: February 2, 2010
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Aleardo Koverech, Nicola Pescosolido
  • Publication number: 20070265338
    Abstract: Use of L-carnitine and/or of one or more alkanoyl L-carnitines or one of their pharmaceutically acceptable salts for the preparation of an opthalmic physiological supplement or medicament in the form of eye-drops, for the treatment of corneal diseases.
    Type: Application
    Filed: December 14, 2006
    Publication date: November 15, 2007
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Aleardo Koverech, Nicola Pescosolido